Society guideline links: Uterine fibroids (leiomyomas)

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Abnormal uterine bleeding".)

International

●AAGL: Practice report – Practice guidelines for the diagnosis and management of submucous leiomyomas (2012)

Canada

●Choosing Wisely Canada: Don't offer hysterectomy to women with asymptomatic fibroids on the basis of risk malignancy (2020)

●Society of Obstetricians and Gynaecologists of Canada (SOGC): Clinical practice guideline for the medical management of symptomatic uterine leiomyomas ─ An addendum (2019)

•SOGC: Clinical practice guideline for the management of uterine leiomyomas (2015)

●SOGC: Clinical practice guideline for the management of uterine fibroids in women with otherwise unexplained infertility (2015)

United States

●American College of Radiology (ACR): ACR Appropriateness Criteria on fibroids (2022)

●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on uterine morcellation for presumed leiomyomas (2021)

●ACOG: Practice bulletin for the management of symptomatic uterine leiomyomas (2021)

●ACOG: Committee opinion on the use of hysteroscopy for the diagnosis and treatment of intrauterine pathology (2020)

●US Food and Drug Administration (FDA): Immediately in effect guidance document – Product labeling for laparoscopic power morcellators: Guidance for industry and Food and Drug Administration staff (2020)

●ACR: ACR Appropriateness Criteria on radiologic management of uterine leiomyomas (2017)

●American Society for Reproductive Medicine (ASRM): Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate – A guideline (2017)

●ACOG: Practice bulletin on the diagnosis of abnormal uterine bleeding in reproductive-aged women (2012)

Europe

●European Society of Urogenital Radiology (ESUR): Guidelines on MR imaging of leiomyomas (2018)

●European Menopause and Andropause Society (EMAS): Position statement for the management of uterine fibroids (2014)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Interventional procedures guidance for hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroids (2021)

●NICE: Interventional procedures guidance for laparoscopic removal of uterine fibroids with power morcellation (2021)

●NICE: Interventional procedures guidance on transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids (2021)

●NICE: Interventional procedures guidance on ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids (2019)

●NICE: Interventional procedures guidance for magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids (2011)

●NICE: Interventional procedures guidance for uterine artery embolisation for fibroids (2010)

Australia–New Zealand

●Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG): Consensus statement on uterine artery embolisation for the treatment of uterine fibroids (2020)

●RANZCOG: Consensus statement on fibroids in infertility (2018)